Our findings align with these studies, showing a significant correlation between BAG3 and NAP1L5, as well as a high positive correlation between NAP1L5 and CD4 resting memory T cells, which are linked to shorter OS in AML patients. This evidence concerns the gene NAP1L5 and acute myeloid leukemia.